Sun pharma is the biggest contributor in the Indian Pharma Index. So far, it has acted like a tired lion however, it seems the lion is ready to claim the kingship all over again.
Sun pharma has broken its 3-year downward trendline. RSI has already passed its complexion point.
It completed its corrective wave (2) at 450 levels around September. It is all set to touch 630, 750 & 800 levels.
800 would be a crucial level to watch and any correction from those levels will be another buying opportunity.
Sun pharma has broken its 3-year downward trendline. RSI has already passed its complexion point.
It completed its corrective wave (2) at 450 levels around September. It is all set to touch 630, 750 & 800 levels.
800 would be a crucial level to watch and any correction from those levels will be another buying opportunity.
免責事項
この情報および投稿は、TradingViewが提供または推奨する金融、投資、トレード、その他のアドバイスや推奨を意図するものではなく、それらを構成するものでもありません。詳細は利用規約をご覧ください。
免責事項
この情報および投稿は、TradingViewが提供または推奨する金融、投資、トレード、その他のアドバイスや推奨を意図するものではなく、それらを構成するものでもありません。詳細は利用規約をご覧ください。